BIO Key Valuation
| BKYI Stock | USD 0.88 0.04 4.76% |
Today, the firm appears to be undervalued. BIO Key International shows a prevailing Real Value of $1.12 per share. The current price of the firm is $0.88. Our model approximates the value of BIO Key International from reviewing the firm fundamentals such as profit margin of (0.92) %, and Return On Equity of -4.58 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting BIO Key's valuation include:
Price Book 19.7506 | Enterprise Value 3.3 M | Enterprise Value Ebitda (0.74) | Price Sales 0.3754 | Enterprise Value Revenue 0.4512 |
Undervalued
Today
Please note that BIO Key's price fluctuation is out of control at this time. Calculation of the real value of BIO Key International is based on 3 months time horizon. Increasing BIO Key's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BIO Key is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BIO Stock. However, BIO Key's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.88 | Real 1.12 | Target 2.0 | Hype 0.83 | Naive 0.57 |
The intrinsic value of BIO Key's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence BIO Key's stock price.
Estimating the potential upside or downside of BIO Key International helps investors to forecast how BIO stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BIO Key more accurately as focusing exclusively on BIO Key's fundamentals will not take into account other important factors: When choosing an evaluation method for BIO Key International, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
BIO Key Cash |
|
BIO Valuation Trend
BIO Key's real value analysis enables investors to forecast the earnings more efficiently. Using both BIO Key's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
BIO Key Total Value Analysis
BIO Key International is currently anticipated to have valuation of 3.29 M with market capitalization of 3.25 M, debt of 365.35 K, and cash on hands of 4.89 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BIO Key fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.29 M | 3.25 M | 365.35 K | 4.89 M |
BIO Key Investor Information
The company recorded a loss per share of 8.66. BIO Key International last dividend was issued on the 20th of November 2020. The entity had 1:18 split on the 21st of December 2023. Based on the key measurements obtained from BIO Key's financial statements, BIO Key International is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in December.BIO Key Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BIO Key has an asset utilization ratio of 171.68 percent. This signifies that the Company is making $1.72 for each dollar of assets. An increasing asset utilization means that BIO Key International is more efficient with each dollar of assets it utilizes for everyday operations.BIO Key Ownership Allocation
BIO Key International shows 5.57 percent of its outstanding shares held by insiders and 5.02 percent owned by other corporate entities.BIO Key Profitability Analysis
The company reported the previous year's revenue of 7.75 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 3.44 M.About BIO Key Valuation
An absolute valuation paradigm, as applied to BIO Stock, attempts to find the value of BIO Key International based on its fundamental and basic technical indicators. By analyzing BIO Key's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of BIO Key's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of BIO Key. We calculate exposure to BIO Key's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BIO Key's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.4 M | 1.4 M | |
| Pretax Profit Margin | (1.12) | (1.06) | |
| Operating Profit Margin | (1.14) | (1.20) | |
| Net Loss | (1.10) | (1.15) | |
| Gross Profit Margin | 0.18 | 0.18 |
BIO Key Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 560.3 K |
BIO Key Current Valuation Indicators
Valuation refers to the process of determining the present value of BIO Key International and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value BIO we look at many different elements of the entity such as BIO's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as BIO Key, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use BIO Key's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes BIO Key's worth.Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |